ACI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Archean Chemical Industries has submitted its Annual Report for FY 2025-26. Standalone revenue grew 2.74% to Rs. 1,04,154 Lakhs, but net profit declined to Rs. 15,437 Lakhs from Rs. 18,492 Lakhs in FY 2024-25, impacted by higher fuel prices and increased logistics costs. Consolidated revenue was Rs. 1,08,105 Lakhs with net profit of Rs. 10,541 Lakhs. The company declared a dividend of Rs. 2.50 per share (125% payout). Key highlights include 22% volume growth in industrial salt, 202% revenue growth in bromine derivatives (Acume Chemicals), and strategic investments in semiconductor materials (SiCSem - India's first ISM-approved compound semiconductor project) and zinc-bromide battery technology (Offgrid Energy Labs). Exports contributed 78% of operating revenue. The company faced headwinds from bromine production due to climatic conditions and Middle East crisis-related disruptions.
While revenue remained stable, profit decline due to cost pressures may weigh on near-term sentiment. However, aggressive expansion into high-margin derivatives and advanced materials (semiconductors, battery tech) positions the company for future growth, potentially supporting long-term valuation.